Skip to content

Precision Prescribing for Metabolic Health

The rising use of GLP-1 medications presents both opportunities and challenges for healthcare management. Our genomic solutions offer a targeted approach to metabolic health, enabling more precise prescribing practices and personalized interventions. By leveraging clinico-genomic insights, we help identify individuals most likely to benefit from GLP-1 therapies, optimize dosing, and explore alternative treatments when appropriate.

Connect with us

Optimizing GLP-1 Utilization Through Clinico-genomics

Our clinico-genomic approach to metabolic health management provides a nuanced strategy for addressing GLP-1 utilization, focusing on personalized treatment plans and long-term health outcomes.

Identify Ideal Candidates

Use clinical and genetic markers to pinpoint individuals most likely to respond positively to GLP-1 therapies, ensuring resources are allocated effectively.

Personalize Treatment Plans

Leverage clinico-genomic insights to optimize GLP-1 dosing and duration, potentially improving outcomes and reducing unnecessary prescriptions

Explore Alternative Interventions

For individuals less likely to benefit from GLP-1s, identify data-informed alternative treatments or lifestyle interventions.

Monitor Long-term Efficacy

Use clinico-genomic data to track treatment responses over time, enabling timely adjustments to maintain effectiveness and manage costs.

Pioneering Precision in Metabolic Health

Helix provides a unique, clinico-genomics first approach to metabolic health management. Our advanced analytics platform offers insights that go beyond traditional clinical factors, enabling truly personalized treatment strategies. With Helix, you're equipped to make data-driven decisions about GLP-1 therapies, optimizing their use while exploring complementary or alternative approaches for comprehensive metabolic health management.

Abstract shapes with light colors for the background

Partner Perspectives

Learn more about population health programs powered by Helix

HealthPartners has launched myGenetics, a population genomics program that will provide important health information to families across Minnesota and surrounding states.

For more information about our partners, see: partner page or resource center

More from Helix

Dive deeper into the world of genomics and its impact on healthcare. Our selection of insights, case studies, and expert analyses offer valuable perspectives to support your journey in leveraging genomics for healthcare transformation.

Press Releases

Helix Launches World's Largest Clinico-Genomic Cohort of GLP-1 Agonist Treated Patients

Read More

Blog

GLP-1 Spending Is Spiraling — But There's a Smarter Way Forward

Read More

Metabolic risk factors and BMI-associated variants influencing weight loss with Semaglutide

Read More

A Selection of Our Partners

Cone Health
HealthPartners
MUSC Logo
Memorial Hermann
Nebraska Medicine
Providence Logo
Renown Health logo
Sanford Health Logo
St Luke's University Health Network logo
WellSpan Health Logo
tOSU Wexner Medical Center logo
WakeMed Logo
TriHealth Logo
Parkview Health Logo
Rochester Regional Health logo

Connect with us!